A Phase I/II Randomised, Double-blind, Placebo-controlled, Single Centre Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of Two Concentrations of XF-73 Nasal Gel in Healthy Subjects.
Phase of Trial: Phase I/II
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Exeporfinium chloride (Primary) ; Chlorhexidine
- Indications Staphylococcal infections
- Focus Therapeutic Use
- Sponsors Destiny Pharma
- 17 Feb 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 07 Nov 2014 New trial record